Skip to main content
. 2011 Oct 10;11:780. doi: 10.1186/1471-2458-11-780

Table 3.

Outcomes for studies on integrated delivery of mental health and substance abuse services

Type of outcome Study Measure Outcome (Intervention vs. Control)
Health outcomes Druss 2001 Change in physical component summary index. +4.7% vs. -0.3%, (p < 0.001)
Change in mental component summary index. +2.4% vs. +2%, (p = 0.84)

Krahn 2006 Change in Centre for Epidemiological Studies Depression scale (CES-D) score. Patients with all depression:
-6.0 ± 12.0 vs. -7.8 ± 11.8, (p = 0.07)
Patients with major depression:
-7.5 ± 13.1 vs. -10.2 ± 12.1, (p = 0.003)
Change in Medical Component Score (MCS). Patients with all depression:
+4.8 ± 12.6 vs. +4.9 ± 12.9, (p = 0.88)
Patients with major depression:
+5.9 ± 12.6 vs. + 6.8 ± 12.8, (p = 0.32)

Willenbring 1999 Number of patients with 2-year survival. 31/38 (81%) vs. 26/37 (70%), (p = 0.03)

Drug and alcohol use Oslin 2006 Change in number of drinks per week. -6.0 vs. -5.9 (p = 0.913)
Change in number of binge episodes in the preceding three months. -8.5 vs. -10.2 (p = 0.750)

Weisner 2001 Total abstinence and duration of abstinence. Non-SAMC patients:
66% vs. 73%, (p = 0.23)
SAMC patients:
69% vs. 55%, (p = 0.006); period of abstinence 135 days vs. 122 days, (p = 0.05)

Alcohol abstinence. Non-SAMC patients:
73% vs. 78% (p = 0.41)
SAMC patients:
80% vs. 65%, (p = 0.002)

Other drug abstinence Non-SAMC patients:
84% vs. 87%, (p = 0.50)

Willenbring 1999 Number of patients with alcohol abstinence after 2 years. 28/38 (74%) vs. 17/36 (48%), (p = 0.02)

Patient satisfaction Druss 2001 Satisfaction score on 47-item questionnaire. Patients in integrated model were more satisfied with overall care received in 6 of 8 domains (access, attention to patient preferences, courtesy, coordination, continuity, and overall care) (p < 0.05 on all 6 domains)

Gater 1997 Score on Client Satisfaction Questionnaire (range 1-4; low score indicates higher satisfaction). 1.86 vs. 2.23

Quality of care Druss 2001 Delivery of preventive measures outlined in clinical guidelines. Patients in integrated model (n = 59) more likely than in control group (n = 61) to receive 15 of 17 measures, (p < 0.01)

Gater 1997 Number of clinical needs met; and unmet. 2.62 vs. 1.60, (p < 0.001);
0.57 vs. 1.62 (p < 0.001)
Number of social needs met; and unmet. 1.83 vs. 1.49, (p = NS); 0.86 vs. 1.64 (p < 0.05)

Watts 2007 Patients who screened positive for depression and received treatment in accordance with guidelines. From 1.1% to 11.2% vs. from 3.0% to 0.7%, (p < 0.001)

Utilisation of services Bartels 2004 Mean number of mental health and substance abuse visits. 3.04 vs. 1.91 (p ≤ 0.001)
Appointment attendance. 71% vs. 48.8% (95% CI = 2.14 to 3.08)

Druss 2001 Patients who used a medical: Primary care service; Specialty service;
Emergency department;
Inpatient service.
54/59 (91.5%) vs. 44/61 (72.1%), (p = 0.006);
41/59 (69.5%) vs. 41/61 (67.2%), (p = 0.17);
7/59 (11.9%) vs. 16/61 (26.2%), (p = 0.04);
5/59 (8.5%) vs. 11/61 (18%), (p = 0.12)
Patients who used a mental health:
Outpatient service; Emergency department; Inpatient service.
58/59 (98.3%) vs. 61/61 (100%), (p = 0.31);
21/59 (35.6%) vs. 25/61 (41%), (p = 0.31);
8/59 (13.6%) vs. 10/61 (16.4%), (p = 0.66)

Willenbring 1999 Mean number of IOT visits in 2 years. 42.2 ± 29.1 vs. 17.4 ± 15.6, (p < 0.001)
Mean number of IOT visits in first and last 6 months of treatment. From 14 to 9 vs. 4-6 in both periods

Access to health care Watts 2007 Patients who screened positive and were able to access mental health services. 36.0% vs. 9%, (p < 0.001)

Cost Druss 2001 Mean cost per subject treated US$ 13,010 vs. US$ 14,543

Gater 1997 Overall per capita health service cost £ 1,406 vs. £ 1,199

Weisner 2001 Average cost of all treatment per month US$ 470.81 vs. US$ 427.95, (p = 0.14)